Modulation of the lipopolysaccharide receptor complex (CD14, TLR4, MD-2) and toll-like receptor 2 in systemic inflammatory response syndrome-positive patients with and without infection: relationship to tolerance.

Jacqueline E. Calvano, Doreen M. Agnese, John Y. Um, Masahiro Goshima, Ritu Singhal, Susette M. Coyle, Michael T. Reddell, Ashwini Kumar, Steve E. Calvano, Stephen F. Lowry

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

The lipopolysaccharide (LPS) receptor complex consists of two interacting receptors (CD14 and TLR4) and an associated protein (MD-2). When engaged by LPS, as in gram-negative infection, this complex transduces a signal detected by MyD88 and passed onward by a cascade of the IRAKs, TRAF6, and NIK, resulting in activation of NF-kappaB. A similar cascade, mediated by TLR2, occurs with ligands derived from gram-positive bacteria. In vitro studies of human monocytes have shown that TLR4 mRNA is paradoxically upregulated in response to "tolerizing" doses of LPS. This study evaluated changes in vivo of blood monocyte CD14, TLR4, TLR2, and MD-2 mRNA by reverse transcription followed by real-time polymerase chain reaction in surgical intensive care unit patients and in normal controls. In addition cell-surface receptor expression of TLR2, TLR4, and CD14 was assessed by flow cytometry in patients and normal controls. Inflammation-induced acute tolerance to LPS was evaluated by ex vivo whole blood tumor necrosis factor alpha production and was significantly reduced in patients compared with controls, confirming LPS hyporesponsiveness. Monocyte mRNA and cell-surface receptor expression of TLR4 were increased 2.4-fold (P < 0.05) and 1.7-fold (P <.002), respectively, in patients compared with normal controls. Monocyte TLR2 mRNA, MD-2 mRNA and CD14 and TLR2 cell-surface expression were not significantly changed compared with controls. The present study suggests that the acute inflammatory condition associated with peripheral cellular LPS hyporesponsiveness is neither specific to prior infectious challenge nor can be ascribed to significant alterations in expression of the cell-surface LPS binding complex proteins.

Original languageEnglish (US)
Pages (from-to)415-419
Number of pages5
JournalShock (Augusta, Ga.)
Volume20
Issue number5
DOIs
StatePublished - Nov 2003

Fingerprint

CD14 Antigens
Toll-Like Receptor 2
Systemic Inflammatory Response Syndrome
Lipopolysaccharides
Monocytes
Messenger RNA
Infection
Cell Surface Receptors
Lymphocyte Antigen 96
TNF Receptor-Associated Factor 6
Toll-Like Receptor 4
NF-kappa B
Gram-Positive Bacteria
Critical Care
Reverse Transcription
Intensive Care Units
Real-Time Polymerase Chain Reaction
Flow Cytometry
Tumor Necrosis Factor-alpha
Ligands

ASJC Scopus subject areas

  • Emergency Medicine
  • Critical Care and Intensive Care Medicine

Cite this

Modulation of the lipopolysaccharide receptor complex (CD14, TLR4, MD-2) and toll-like receptor 2 in systemic inflammatory response syndrome-positive patients with and without infection : relationship to tolerance. / Calvano, Jacqueline E.; Agnese, Doreen M.; Um, John Y.; Goshima, Masahiro; Singhal, Ritu; Coyle, Susette M.; Reddell, Michael T.; Kumar, Ashwini; Calvano, Steve E.; Lowry, Stephen F.

In: Shock (Augusta, Ga.), Vol. 20, No. 5, 11.2003, p. 415-419.

Research output: Contribution to journalArticle

Calvano, Jacqueline E. ; Agnese, Doreen M. ; Um, John Y. ; Goshima, Masahiro ; Singhal, Ritu ; Coyle, Susette M. ; Reddell, Michael T. ; Kumar, Ashwini ; Calvano, Steve E. ; Lowry, Stephen F. / Modulation of the lipopolysaccharide receptor complex (CD14, TLR4, MD-2) and toll-like receptor 2 in systemic inflammatory response syndrome-positive patients with and without infection : relationship to tolerance. In: Shock (Augusta, Ga.). 2003 ; Vol. 20, No. 5. pp. 415-419.
@article{5041a185c4ca4beea8a1c3304f1adf22,
title = "Modulation of the lipopolysaccharide receptor complex (CD14, TLR4, MD-2) and toll-like receptor 2 in systemic inflammatory response syndrome-positive patients with and without infection: relationship to tolerance.",
abstract = "The lipopolysaccharide (LPS) receptor complex consists of two interacting receptors (CD14 and TLR4) and an associated protein (MD-2). When engaged by LPS, as in gram-negative infection, this complex transduces a signal detected by MyD88 and passed onward by a cascade of the IRAKs, TRAF6, and NIK, resulting in activation of NF-kappaB. A similar cascade, mediated by TLR2, occurs with ligands derived from gram-positive bacteria. In vitro studies of human monocytes have shown that TLR4 mRNA is paradoxically upregulated in response to {"}tolerizing{"} doses of LPS. This study evaluated changes in vivo of blood monocyte CD14, TLR4, TLR2, and MD-2 mRNA by reverse transcription followed by real-time polymerase chain reaction in surgical intensive care unit patients and in normal controls. In addition cell-surface receptor expression of TLR2, TLR4, and CD14 was assessed by flow cytometry in patients and normal controls. Inflammation-induced acute tolerance to LPS was evaluated by ex vivo whole blood tumor necrosis factor alpha production and was significantly reduced in patients compared with controls, confirming LPS hyporesponsiveness. Monocyte mRNA and cell-surface receptor expression of TLR4 were increased 2.4-fold (P < 0.05) and 1.7-fold (P <.002), respectively, in patients compared with normal controls. Monocyte TLR2 mRNA, MD-2 mRNA and CD14 and TLR2 cell-surface expression were not significantly changed compared with controls. The present study suggests that the acute inflammatory condition associated with peripheral cellular LPS hyporesponsiveness is neither specific to prior infectious challenge nor can be ascribed to significant alterations in expression of the cell-surface LPS binding complex proteins.",
author = "Calvano, {Jacqueline E.} and Agnese, {Doreen M.} and Um, {John Y.} and Masahiro Goshima and Ritu Singhal and Coyle, {Susette M.} and Reddell, {Michael T.} and Ashwini Kumar and Calvano, {Steve E.} and Lowry, {Stephen F.}",
year = "2003",
month = "11",
doi = "10.1097/01.shk.0000092269.01859.44",
language = "English (US)",
volume = "20",
pages = "415--419",
journal = "Shock (Augusta, Ga.)",
issn = "1073-2322",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Modulation of the lipopolysaccharide receptor complex (CD14, TLR4, MD-2) and toll-like receptor 2 in systemic inflammatory response syndrome-positive patients with and without infection

T2 - relationship to tolerance.

AU - Calvano, Jacqueline E.

AU - Agnese, Doreen M.

AU - Um, John Y.

AU - Goshima, Masahiro

AU - Singhal, Ritu

AU - Coyle, Susette M.

AU - Reddell, Michael T.

AU - Kumar, Ashwini

AU - Calvano, Steve E.

AU - Lowry, Stephen F.

PY - 2003/11

Y1 - 2003/11

N2 - The lipopolysaccharide (LPS) receptor complex consists of two interacting receptors (CD14 and TLR4) and an associated protein (MD-2). When engaged by LPS, as in gram-negative infection, this complex transduces a signal detected by MyD88 and passed onward by a cascade of the IRAKs, TRAF6, and NIK, resulting in activation of NF-kappaB. A similar cascade, mediated by TLR2, occurs with ligands derived from gram-positive bacteria. In vitro studies of human monocytes have shown that TLR4 mRNA is paradoxically upregulated in response to "tolerizing" doses of LPS. This study evaluated changes in vivo of blood monocyte CD14, TLR4, TLR2, and MD-2 mRNA by reverse transcription followed by real-time polymerase chain reaction in surgical intensive care unit patients and in normal controls. In addition cell-surface receptor expression of TLR2, TLR4, and CD14 was assessed by flow cytometry in patients and normal controls. Inflammation-induced acute tolerance to LPS was evaluated by ex vivo whole blood tumor necrosis factor alpha production and was significantly reduced in patients compared with controls, confirming LPS hyporesponsiveness. Monocyte mRNA and cell-surface receptor expression of TLR4 were increased 2.4-fold (P < 0.05) and 1.7-fold (P <.002), respectively, in patients compared with normal controls. Monocyte TLR2 mRNA, MD-2 mRNA and CD14 and TLR2 cell-surface expression were not significantly changed compared with controls. The present study suggests that the acute inflammatory condition associated with peripheral cellular LPS hyporesponsiveness is neither specific to prior infectious challenge nor can be ascribed to significant alterations in expression of the cell-surface LPS binding complex proteins.

AB - The lipopolysaccharide (LPS) receptor complex consists of two interacting receptors (CD14 and TLR4) and an associated protein (MD-2). When engaged by LPS, as in gram-negative infection, this complex transduces a signal detected by MyD88 and passed onward by a cascade of the IRAKs, TRAF6, and NIK, resulting in activation of NF-kappaB. A similar cascade, mediated by TLR2, occurs with ligands derived from gram-positive bacteria. In vitro studies of human monocytes have shown that TLR4 mRNA is paradoxically upregulated in response to "tolerizing" doses of LPS. This study evaluated changes in vivo of blood monocyte CD14, TLR4, TLR2, and MD-2 mRNA by reverse transcription followed by real-time polymerase chain reaction in surgical intensive care unit patients and in normal controls. In addition cell-surface receptor expression of TLR2, TLR4, and CD14 was assessed by flow cytometry in patients and normal controls. Inflammation-induced acute tolerance to LPS was evaluated by ex vivo whole blood tumor necrosis factor alpha production and was significantly reduced in patients compared with controls, confirming LPS hyporesponsiveness. Monocyte mRNA and cell-surface receptor expression of TLR4 were increased 2.4-fold (P < 0.05) and 1.7-fold (P <.002), respectively, in patients compared with normal controls. Monocyte TLR2 mRNA, MD-2 mRNA and CD14 and TLR2 cell-surface expression were not significantly changed compared with controls. The present study suggests that the acute inflammatory condition associated with peripheral cellular LPS hyporesponsiveness is neither specific to prior infectious challenge nor can be ascribed to significant alterations in expression of the cell-surface LPS binding complex proteins.

UR - http://www.scopus.com/inward/record.url?scp=2942638466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2942638466&partnerID=8YFLogxK

U2 - 10.1097/01.shk.0000092269.01859.44

DO - 10.1097/01.shk.0000092269.01859.44

M3 - Article

C2 - 14560104

AN - SCOPUS:2942638466

VL - 20

SP - 415

EP - 419

JO - Shock (Augusta, Ga.)

JF - Shock (Augusta, Ga.)

SN - 1073-2322

IS - 5

ER -